Amjad Abdul Anwari, Ph.D., is the analytical project leader for NCE as well as generics. Dr. Anwari has extensive pharmaceutical experience in analytical research and development for drug substance and drug products in a cGMP environment, and a thorough understanding of ICH and FDA guidelines. He leads a team of Chemical Medicines and Excipients Scientific Liaisons as well as Publications staff, ensuring alignment with the overall program unit and United States Pharmacopeia’s goals. Previously associated with Pfizer, Johnson & Johnson as well as Cipla to work on NDA as well as ANDA projects. Holding FDA approved certificate for chemical testing as well as Instrumental testing. Delivered presentation on Extractables & Leachables in Global Public forum like PDA.